Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Lanzetta

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
European Journal of Ophthalmology|January 7, 2025
Anti-complement intravitreal agents for geographic atrophy: A missed opportunity for European patients?Paolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 20, 2021
Anti-VEGF therapies for age-related macular degeneration: a powerful tactical gear or a blunt weapon? The choice is oursPaolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 14, 2003
New treatments for CNV secondary to AMD: what evidence exists to supports a treatment recommendation?Paolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 21, 2017
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseasesPaolo Lanzetta, Anat Loewenstein,
Indian Journal of Ophthalmology|July 31, 2004
Major ocular complications after organ transplantationPaolo Lanzetta, Pietro Monaco
Journal of Clinical Medicine|October 14, 2022
Optical Coherence Tomography Findings in Rhegmatogenous Retinal Detachment: A Systematic ReviewCarla Danese, Paolo Lanzetta
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 17, 2013
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: impact of different photodynamic therapy parametersDaniele Veritti, Paolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 5, 2026
Letter to the editorPaolo Lanzetta, Carla Danese
European Journal of Ophthalmology|October 6, 2021
Combined transconjunctival sutureless three-port vitrectomy and scleral fixation of intraocular lensCarla Danese, Paolo Lanzetta
Eye (London, England)|January 29, 2025
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMDDaniele Veritti, Valentina Sarao, Paolo Lanzetta
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
European Journal of Ophthalmology|January 7, 2025
Anti-complement intravitreal agents for geographic atrophy: A missed opportunity for European patients?Paolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 20, 2021
Anti-VEGF therapies for age-related macular degeneration: a powerful tactical gear or a blunt weapon? The choice is oursPaolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 14, 2003
New treatments for CNV secondary to AMD: what evidence exists to supports a treatment recommendation?Paolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 21, 2017
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseasesPaolo Lanzetta, Anat Loewenstein,
Indian Journal of Ophthalmology|July 31, 2004
Major ocular complications after organ transplantationPaolo Lanzetta, Pietro Monaco
Journal of Clinical Medicine|October 14, 2022
Optical Coherence Tomography Findings in Rhegmatogenous Retinal Detachment: A Systematic ReviewCarla Danese, Paolo Lanzetta
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 17, 2013
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: impact of different photodynamic therapy parametersDaniele Veritti, Paolo Lanzetta
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 5, 2026
Letter to the editorPaolo Lanzetta, Carla Danese
European Journal of Ophthalmology|October 6, 2021
Combined transconjunctival sutureless three-port vitrectomy and scleral fixation of intraocular lensCarla Danese, Paolo Lanzetta
Eye (London, England)|January 29, 2025
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMDDaniele Veritti, Valentina Sarao, Paolo Lanzetta
Pageof 20